Table 3 Pre- and per-operative data
SRCC (n = 46) | Non-SRCC (n = 45) | p | |
|---|---|---|---|
ASA score | 0.950 | ||
1 | 34 (73.9) | 32 (71.1) | |
2 | 9 (19.6) | 10 (22.2) | |
3 | 3 (6.5) | 3 (6.7) | |
WHO score | 0.617 | ||
1 | 18 (39.1) | 16 (35.6) | |
2 | 16 (34.8) | 19 (42.2) | |
v3 | 12 (26.1) | 9 (20) | |
Tumor size (mm) | 63.9 ± 29.4 | 68.4 ± 37.8 | 0.55 |
Distal metastasis | |||
Hepatic | 0 | 4 (8.9%) | 0.039 |
Other | 0 | 2 | 0.15 |
Local organ invasion | 6 (13.3) | 4 (8.7) | |
Carcinomatosis | 2 | 1 | 0.57 |
Gastrectomy | |||
Subtotal | 6 (13%) | 20 (44%) | 0.001 |
Total | 40 (87%) | 25 (56%) | |
Lymph node dissection | |||
D1 | 2 | 4 (9%) | 0.38 |
D2 | 44 (96%) | 41 (91%) | |
Quality of dissection | |||
R0 | 36 (78%) | 38 (84%) | 0.063 |
R1 | 7 (15%) | 1 | |
R2 | 3 (7%) | 6 (13.3%) | |